Critical issues of the regulatory pathway for nanostructured medical devices
暂无分享,去创建一个
[1] Ricardas Rotomskis,et al. Accumulation and Toxicity of Superparamagnetic Iron Oxide Nanoparticles in Cells and Experimental Animals , 2016, International journal of molecular sciences.
[2] Gert Fricker,et al. Nanotoxicity of poly(n-butylcyano-acrylate) nanoparticles at the blood-brain barrier, in human whole blood and in vivo. , 2015, Journal of controlled release : official journal of the Controlled Release Society.
[3] A. Lupu,et al. The noncellular reduction of MTT tetrazolium salt by TiO₂ nanoparticles and its implications for cytotoxicity assays. , 2013, Toxicology in vitro : an international journal published in association with BIBRA.
[4] H. Krug,et al. Oops they did it again! Carbon nanotubes hoax scientists in viability assays. , 2006, Nano letters.